CA2379676A1 - Conception de stabilisateurs de polymerisation de la tubuline - Google Patents
Conception de stabilisateurs de polymerisation de la tubuline Download PDFInfo
- Publication number
- CA2379676A1 CA2379676A1 CA002379676A CA2379676A CA2379676A1 CA 2379676 A1 CA2379676 A1 CA 2379676A1 CA 002379676 A CA002379676 A CA 002379676A CA 2379676 A CA2379676 A CA 2379676A CA 2379676 A1 CA2379676 A1 CA 2379676A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- substituted
- acid
- chain
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/14—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
L'invention concerne un procédé permettant la conception de composés de remplacement du paclitaxel, qui stabilisent le processus de polymérisation de la tubuline. Ces composés en solution présentent les caractéristiques de conformation stérique du paclitaxel naturel et sont capables de se fixer à la protéine de tubuline au même site de liaison que le paclitaxel. Ces composés stabilisent la polymérisation de la tubuline par un mécanisme correspondant au mécanisme d'activité du paclitaxel. Comparés au paclitaxel naturel, ces composés présentent une solubilité accrue, sont plus faciles à synthétiser et offrent des possibilités de réactions combinatoires permettant une spécificité et d'une optimisation.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14397399P | 1999-07-15 | 1999-07-15 | |
US60/143,973 | 1999-07-15 | ||
US17189299P | 1999-12-23 | 1999-12-23 | |
US60/171,892 | 1999-12-23 | ||
PCT/US2000/019524 WO2001005779A2 (fr) | 1999-07-15 | 2000-07-17 | Conception de stabilisateurs de polymerisation de la tubuline |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2379676A1 true CA2379676A1 (fr) | 2001-01-25 |
Family
ID=26841562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002379676A Abandoned CA2379676A1 (fr) | 1999-07-15 | 2000-07-17 | Conception de stabilisateurs de polymerisation de la tubuline |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1198461A2 (fr) |
AU (1) | AU6108300A (fr) |
CA (1) | CA2379676A1 (fr) |
WO (1) | WO2001005779A2 (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4349552A (en) * | 1978-10-30 | 1982-09-14 | Fujisawa Pharmaceutical Company, Ltd. | 5-Fluorouracil derivatives, and their pharmaceutical compositions |
DE69313649D1 (en) * | 1992-06-19 | 1997-10-09 | Black James Foundation | Bicyclooctan und bicycloheptan derivate |
US5302589A (en) * | 1992-08-07 | 1994-04-12 | Glaxo, Inc. | Heterocyclic inhibitors of 5-α-testosterone reductase |
US5658940A (en) * | 1995-10-06 | 1997-08-19 | Celgene Corporation | Succinimide and maleimide cytokine inhibitors |
-
2000
- 2000-07-17 WO PCT/US2000/019524 patent/WO2001005779A2/fr not_active Application Discontinuation
- 2000-07-17 CA CA002379676A patent/CA2379676A1/fr not_active Abandoned
- 2000-07-17 EP EP00947487A patent/EP1198461A2/fr not_active Withdrawn
- 2000-07-17 AU AU61083/00A patent/AU6108300A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001005779A3 (fr) | 2001-08-16 |
EP1198461A2 (fr) | 2002-04-24 |
AU6108300A (en) | 2001-02-05 |
WO2001005779A2 (fr) | 2001-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Slee et al. | Selectivity in the inhibition of HIV and FIV Protease: inhibitory and mechanistic studies of pyrrolidine-containing. alpha.-Keto amide and hydroxyethylamine core structures | |
JPH1192468A (ja) | 新規なタキサン誘導体 | |
Fang et al. | Recent progress in structure activity relationship and mechanistic studies of taxol analogues | |
CA2359561A1 (fr) | Inhibiteurs de proteasome | |
CA2337771A1 (fr) | Anhydrides analogues de cantharidine modifiee utiles pour traiter le cancer | |
JP3759602B2 (ja) | セファロマニンの酸化生成物 | |
Wang et al. | Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma | |
CN107207525A (zh) | C14‑位羟基酯化的雷公藤甲素氨基酸衍生物、及其制备方法和应用 | |
Egbewande et al. | The design, synthesis, and anti-inflammatory evaluation of a drug-like library based on the natural product valerenic acid | |
CA2379676A1 (fr) | Conception de stabilisateurs de polymerisation de la tubuline | |
CN115010658B (zh) | 一种化合物及其制备方法与应用 | |
Bryans et al. | An in vitro investigation into conformational aspects of gabapentin | |
CN104395325B (zh) | 带有硼酸的LIPHAGANE化合物作为PI3K-α和/或β的抑制剂 | |
FR2569696A1 (fr) | Nouveaux analogues de la mitomycine, leur procede de preparation et leur application pharmaceutique | |
Debnath et al. | QSAR Study on 5–N–Substituted–2–(Substituted Benzenesulphonyl) Glutamines as Antitumor Agents through Synthesis and Biological Evaluation: Part III, Internet Electron | |
Faissat et al. | New nitrogen mustards structurally related to (L)-carnitine | |
CN113292627B (zh) | Nqo1靶向的吲哚醌类23-羟基白桦酸衍生物、制备方法及用途 | |
CN114605418B (zh) | 一类具有抗肿瘤活性的依鲁替尼丙烯酰胺类衍生物及其合成方法与应用 | |
JP7389809B2 (ja) | 合成新規ピロロイミノキノンアルカロイド及び使用の方法 | |
Altmann et al. | On the Chemistry and Biology of the Marine Macrolides Zampanolide and Dactylolide | |
Fang et al. | Structure modifications and their influences on antitumor and other related activities of taxol and its analogs | |
Omran et al. | Anti-Cancer Activity, DFT and molecular docking study of new BisThiazolidine amide | |
Pitushkin et al. | Ureas derived from camphor and fenchone reveal enantiomeric preference of human soluble epoxide hydrolase. | |
Lóránd et al. | Diastereoselective reduction of cyclic bioactive Mannich ketones | |
Leung | Exploiting functional groups that are rare in Nature for applications in medicinal chemistry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |